TAM
MAIA icon

Tucker Asset Management’s MAIA Biotechnology MAIA Stock Holding History

Tucker Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-341
Closed -$522 – 758
2025
Q4 		$522 Buy
+341
New +$445 ﹤0.01% 993
2025
Q1 		– Sell
-341
Closed -$675 – 662
2024
Q4 		$675 Buy
+341
New +$818 ﹤0.01% 1383

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tucker Asset Management's MAIA Position: Q1 2026 in Review

Tucker Asset Management sold out of MAIA Biotechnology (MAIA) in Q1 2026, closing a stake of 341 shares — an estimated $522 sold.

Tucker Asset Management first reported a position in MAIA in Q4 2024 and held it in 2 quarters. The position peaked at $675 in Q4 2024. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Tucker Asset Management reported no remaining MAIA Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 341 MAIA Biotechnology shares in Q1 2026, an estimated $522.
  • Tucker Asset Management first reported a position in MAIA Biotechnology in Q4 2024 and held it in 2 quarters.
  • Tucker Asset Management's MAIA Biotechnology position peaked at $675 in Q4 2024.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.